Attached files
| file | filename |
|---|---|
| EX-10.4 - EX-10.4 - Landos Biopharma, Inc. | d89081dex104.htm |
| EX-10.1 - EX-10.1 - Landos Biopharma, Inc. | d89081dex101.htm |
| EX-3.2 - EX-3.2 - Landos Biopharma, Inc. | d89081dex32.htm |
| EX-3.1 - EX-3.1 - Landos Biopharma, Inc. | d89081dex31.htm |
| S-1 - S-1 - Landos Biopharma, Inc. | d89081ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2020, in the Registration Statement (Form S-1) and related Prospectus of Landos BioPharma, Inc. dated January 13, 2021.
| /s/ Ernst & Young LLP |
Raleigh, North Carolina
January 13, 2021